Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -96.8% | -135.7% |
ROCE | 1632.2% |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 7.9 | 7.4 |
Pr/Book | 8.4 |
Latest | F'cast | |
---|---|---|
Revenue | 140.8% | 5.6% |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | 5.51 | (18.05) | (12.98)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | 2.14 | (18.86) | (7.27)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 2.94 | (29.19) | (10.57)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 9.65 | (41.64) | (14.48)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 23.25 | (27.32) | (9.15)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-24 | 24.56 | (33.34) | (7.97)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-25 | 27.26 | (32.51) | (8.47)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 21.60 | (29.15) | (6.45)p | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
Completion of Dose Escalation and RDE Arms | 12-Dec-2024 | 07:00 | RNS |
R&D Spotlight focusing on pipeline advances | 30-Oct-2024 | 07:00 | RNS |
Block Listing Six Monthly Return | 28-Oct-2024 | 07:00 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 49.50p |
Change Today | 1.50p |
% Change | 3.13 % |
52 Week High | 117.00 |
52 Week Low | 39.75 |
Volume | 1,678,933 |
Shares Issued | 369.31m |
Market Cap | £182.81m |
Beta | 1.40 |
RiskGrade | 461 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 1 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
No dividends found |
Time | Volume / Share Price |
12:29 | 250 @ 49.69p |
12:26 | 9,936 @ 50.26p |
12:26 | 1,119 @ 50.28p |
12:26 | 20,683 @ 50.26p |
12:25 | 1,178 @ 50.26p |
CFO | Tony Peter Gardiner |
CEO | Christina Coughlin |
You are here: research